Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 6/20 | 0.58 |
| ▸ | FPR1 | P21462 | 3/20 | 0.58 |
| ▸ | CTSL | P07711 | 2/20 | 0.57 |
| ▸ | BRS3 | P32247 | 4/20 | 0.54 |
| ▸ | CTSS | P25774 | 1/20 | 0.54 |
| ▸ | CTSK | P43235 | 1/20 | 0.54 |
| ▸ | NMBR | P28336 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6021425 | 0.86 | BRS3 (0.68) | CTSLBRS3CTSSCTSKNMBR | |
| SCHEMBL6020673 | 0.83 | EPHX2 (0.61) | FPR2FPR1CTSLBRS3CTSS | |
| SCHEMBL6020911 | 0.82 | CTSL (0.83) | CTSLBRS3CTSSCTSKNMBR | |
| SCHEMBL6021350 | 0.82 | CTSL (0.66) | CTSLBRS3CTSSCTSKNMBR | |
| SCHEMBL6021290 | 0.82 | CTSL (0.61) | CTSLBRS3CTSSCTSKNMBR | |
| SCHEMBL6020268 | 0.82 | FPR2 (0.60) | FPR2FPR1CTSLBRS3CTSS | |
| SCHEMBL6021229 | 0.81 | GAA (0.64) | CTSLBRS3CTSSCTSK | |
| SCHEMBL6020002 | 0.81 | CTSL (0.55) | FPR2FPR1CTSLBRS3CTSS | |
| SCHEMBL6020042 | 0.81 | CTSL (0.62) | CTSLBRS3CTSSCTSKNMBR | |
| SCHEMBL6021893 | 0.81 | TACR1 (0.53) | FPR2FPR1CTSLCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060252813-A1 | Apparatus for curing a composite laminate | JERINI AG (DE) | 2006-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252813-A1 | Apparatus for curing a composite laminate | DHX29, HDHD5, DHRS9 | FPR2 3247/4885FPR1 3451/4885CTSL 2274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.